Retinal Toxicity in Patients Treated With Hydroxychloroquine: A Cross-Sectional Study

Hydroxychloroquine (HCQ) is an antimalarial medication that can also be used to treat autoimmune diseases. However, it can produce irreversible changes to the retina that lead to visual impairment. The aim of this study was to determine the proportion of patients treated with HCQ who develop retinal...

Descripción completa

Detalles Bibliográficos
Autores principales: ESPANDAR, Goldis, MOGHIMI, Jamileh, GHORBANI, Raheb, POURAZIZI, Mohsen, SEIRI, Mohammad-Ali, KHOSRAVI, Shervin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medical Hypothesis, Discovery & Innovation Ophthalmology 2016
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5347188/
https://www.ncbi.nlm.nih.gov/pubmed/28293646

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5347188/
https://www.ncbi.nlm.nih.gov/pubmed/28293646

Ejemplares similares